- US11932671utility2024Modified Meningococcal Fhbp Polypeptides0 cites
- US11918643utility2024RNA Vaccine Against Sars-cov-2 Variants0 cites
- US11913001utility2024Immunisation of Large Mammals with Low Doses of RNA0 cites
- US11896636utility2024Immunogenic Combination Compositions and Uses Thereof0 cites
- US11891608utility2024Immunization of Large Mammals with Low Doses of RNA0 cites
- US11883534utility2024Immunisation with Lipid Formulations with RNA Encoding Immunogens0 cites
- US11872280utility2024RNA Vaccine Against Sars-cov-2 Variants0 cites
- US11865080utility2024Delivery of RNA to Trigger Multiple Immune Pathways0 cites
- US11857681utility2024Lipid Formulations with RNA Encoding Immunogens0 cites
- US11857562utility2024Delivery of RNA to Trigger Multiple Immune Pathways0 cites
- US11859199utility2024Adenoviral Vectors with Two Expression Cassettes Encoding RSV Antigenic Proteins or Fragments Thereof0 cites
- US11850305utility2023Method of Making Lipid Formulations with RNA Encoding Immunogens0 cites
- US11851660utility2023Immunisation of Large Mammals with Low Doses of RNA0 cites
- US11844828utility2023Vaccine0 cites
- US11845925utility2023Immunisation of Large Mammals with Low Doses of RNA0 cites
- US11839686utility2023Lipid Formulations with Viral Immunogens0 cites
- US11827694utility2023RSV F Protein Compositions and Methods for Making Same0 cites
- US11819544utility2023Immunogenic Composition0 cites
- US11820812utility2023RSV F Protein Compositions and Methods for Making Same0 cites
- US11813323utility2023RSV Immunization Regimen0 cites